Law360, New York (April 20, 2010): Four subsidiaries of German pharmaceutical company Boehringer Ingelheim GmbH have agreed to pay $7.75 million to settle allegations that they overcharged the Wisconsin state Medicaid program by reporting inflated average wholesale drug prices.
